Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company manufactures and sells specialty chemicals, dyes, and pharmaceutical ingredients in India,
Vivimed Labs Limited, is a listed public company incorporated on 22 September, 1988. It is classified as a public limited company and is located in Karnataka., Karnataka. It's authorized share capital is INR 111.00 cr and the total paid-up capital is INR 16.58 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
-19.02%
-70.85%
5.52%
-26.08%
-86.25
-102.2
-154.4
-231.22
-132.18
2.05
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(12)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of Hyderabad
No. of Loans: 6
Total Amount : 460.8 cr
State Bank of India
No. of Loans: 4
Total Amount : 310.6 cr
Allahabad Bank
No. of Loans: 1
Total Amount : 70.0 cr
INTERNATIONAL FINANCE CORPORATION
No. of Loans: 1
Total Amount : 62.5 cr
BANK OF BAHRAIN & KUWAIT B.S.C
No. of Loans: 1
Total Amount : 28.0 cr
Biotechnology Industry Research Assistance Council (BIRAC)
No. of Loans: 2
Total Amount : 0.5 cr
Corporation Bank
No. of Loans: 1
Total Amount : 0.2 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Santosh Varalwar
Shareholder
|
00054763 | 35 years |
| Director | Subhash Varalwar
Shareholder
|
00054789 | 9 years |
| Whole-time Director | Manohar Rao Varalwar
Shareholder
|
00059815 | 9 years |
| Whole-time Director | Sandeep Varalwar
Shareholder
|
01682951 | 16 years |
| Director | Aparna Bidarkar | 05112945 | 3 years |
| Director | Hari Gopal Jamalapuram | 08687353 | 5 years |
| CS | Yugandhar Kopparthi | <HIDDEN> | 12 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| KLAR SEHEN PVT LTD |
Amalgamated
|
70.0 L | 3 | Karnataka |
| B B R PROJECTS PRIVATE LIMITED |
Active
|
1.0 L | 3 | Telangana |
| CREATIVE HEALTHCARE PRIVATE LIMITED |
Amalgamated
|
2.5 Cr | 3 | Maharashtra |
| ANAND EYE INSTITUTE PRIVATE LIMITED |
Active
|
4.0 Cr | 1 | Telangana |
| KREATIVE HOSTS ATRIA PRIVATE LIMITED |
Active
|
25.0 Cr | 2 | Telangana |
| ATRI PHARMA RESEARCH (INDIA) PRIVATE LIMITED |
Active
|
47.8 L | 1 | Telangana |
| UQUIFA INDIA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| VIVIMED LABS (ALATHUR) PRIVATE LIMITED |
Amalgamated
|
50.2 Cr | 3 | Maharashtra |
| V.V.S. PHARMACEUTICALS AND CHEMICALS PRI VATE LIMITED |
Amalgamated
|
3.0 Cr | 2 | Telangana |
| DEMAS PROPERTIES & INFRASTRUCTURES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Telangana |
| VIV LIFE LLP |
Active
|
1.0 L | 1 | Telangana |
| LATTICE PROJEX PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| HUE DESIGNERS PRIVATE LIMITED |
Strike Off
|
6.7 L | 1 | Telangana |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| FINOSO PHARMA PRIVATE LIMITED | Telangana | 2009 | ₹ 3.0 Cr |
| Vivimed Holdings Limited | Hong Kong | - | - |
| Vivimed Labs USA | United States | - | - |
| Vivimed Labs Mauritius Limited | Mauritius | - | - |
| YANTRA GREEN POWER PRIVATE LIMITED | Telangana | 2013 | ₹ 15.0 Cr |
The incorporation date of VIVIMED LABS LIMITED is 22 September, 1988
The authorized share capital of VIVIMED LABS LIMITED is INR ₹ 111.0 Cr.
The paid-up capital of VIVIMED LABS LIMITED is INR ₹ 16.6 Cr.
The registered address of VIVIMED LABS LIMITED is PLOT NO. 78-A,KOLHAR INDUSTRIAL AREA BIDAR KARNATAKA. Karnataka - 585403
The CIN number of VIVIMED LABS LIMITED is L02411KA1988PLC009465.
Expand
Delete
Collapse
See
details
